Screener
USANA Health Sciences USNA Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Core Nutritional | $191.61M-4.0% | $204.4M-3.0% | —— | —— | $199.49M-5.7% | |
| Hiya | $28.26M-16.7% | $32.15M-13.3% | $30.11M+6,013% | $30.85M+6,163% | $33.93M+6,790% | |
| Rise | $3.41M+40.3% | $13.67M+741% | —— | —— | $2.43M— | |
| Concentration risk, percentage by Product | ||||||
| Hiya | 12%-1.0pp | 13%-1.0pp | —— | —— | 13%— | |
| Personal care and skincare | 6%+1.0pp | 5%0.0pp | —— | 5%-1.0pp | 5%0.0pp | |
| Rise | 1%0.0pp | 5%+4.0pp | —— | —— | 1%— | |
| USANA Foods | 8%+2.0pp | 6%+1.0pp | —— | 6%-1.0pp | 6%-1.0pp | |
| USANA® Nutritionals | 73%-2.0pp | 71%-4.0pp | —— | 74%-12.0pp | 75%-12.0pp | |
| Net Sales by Geography | ||||||
| Americas and Europe | $66.13M-8.9% | $80.87M+6.2% | $75.11M+61.8% | $74.23M+84.9% | $72.62M+71.9% | |
| China | $105.35M+3.2% | $112.51M+4.5% | $89.41M-11.8% | $82.62M-9.5% | $102.11M-2.9% | |
| Greater China | $114.61M+1.3% | $123.33M+3.9% | $100.05M-11.1% | $92.57M-9.5% | $113.17M-2.0% | |
| North Asia | $13.81M-19.5% | $15.35M-18.9% | $16.83M+1.7% | $17.69M-13.9% | $17.17M-12.9% | |
| Southeast Asia Pacific | $28.72M-12.7% | $30.66M-14.2% | $34.21M-10.1% | $29.18M-21.7% | $32.89M-7.1% | |
| United States | $49.09M-9.2% | $63.53M+9.7% | $56M+111% | $56.89M+165% | $54.08M+150% |
FAQ
- How does USANA Health Sciences break its business down?
- USANA Health Sciences (USNA) reports net sales by business across 3 parts — Core Nutritional, Hiya and Rise. Each is extracted from the segment footnotes and tracked over time.
- Where does USANA Health Sciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in USANA Health Sciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
